ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.58
+0.10 (1.05%)
Nov 5, 2024, 3:48 PM EST - Market open

ORIC Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-110.78-100.7-89.12-78.72-73.7-26.88
Upgrade
Depreciation & Amortization
1.051.030.970.90.971.03
Upgrade
Loss (Gain) From Sale of Assets
0.010.020.040-0.01
Upgrade
Asset Writedown & Restructuring Costs
----19.84-
Upgrade
Loss (Gain) From Sale of Investments
-8.57-6.17-1.041.350.3-
Upgrade
Stock-Based Compensation
17.7415.2314.4612.855.281.09
Upgrade
Change in Accounts Payable
2.933.28-1.482.934.30.99
Upgrade
Change in Other Net Operating Assets
-2.121.621.031.14-2.260.23
Upgrade
Operating Cash Flow
-99.73-85.69-75.14-59.54-45.27-23.53
Upgrade
Capital Expenditures
-0.69-0.85-2.08-0.94-0.67-0.77
Upgrade
Investment in Securities
-79.77-42.55-107.17159.37-215.49-
Upgrade
Other Investing Activities
----0.19-
Upgrade
Investing Cash Flow
-80.46-43.4-109.25158.44-215.96-0.77
Upgrade
Issuance of Common Stock
126.585.8925.6250.99271.750.13
Upgrade
Other Financing Activities
-0.17-0.23-0.4-1.85-21.24-0.1
Upgrade
Financing Cash Flow
126.3385.6625.2349.13250.5170.82
Upgrade
Net Cash Flow
-53.85-43.43-159.17148.03-10.7146.52
Upgrade
Free Cash Flow
-100.41-86.54-77.22-60.48-45.94-24.3
Upgrade
Free Cash Flow Per Share
-1.59-1.68-1.95-1.59-2.09-12.79
Upgrade
Levered Free Cash Flow
-59.14-49.08-42.02-32.71-23.87-13.5
Upgrade
Unlevered Free Cash Flow
-59.14-49.08-42.02-32.71-23.87-13.5
Upgrade
Change in Net Working Capital
-0.95-4.751.14-3.78-1.39-3.01
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.